What is it? Why is it important?

A manufacturer who puts a Medical Device (MD) on the market (e.g. EU) carries full responsibility for its ongoing safety and error-free performance.

 

Responsibilities include:

  • MD Registration: the manufacturer
    • Assigns the MD with a unique identifier
    • Registers the MD (e.g. Swissdamed, Eudamed)

 

 

 

The Federal Council

  • Defines registration and identification modalities
  • Specifies which technical information and data to document, and how the documentation is made available.

More

The management of the MD vigilance and surveillance system:

Swissmedic is responsible for the management of the system`s database, that include:

  • Access rights
  • Technical measures to ensure data protection and data security
  • Data archiving requirements

 

Swissmedic screens the data with the aim to ensure ongoing MD safety. In the event of adverse events (e.g. SAE, SDE, DD), Swissmedic will contact the marketing holder in order to implement risk control-measures.

Swissmedic is also responsible for the authorisation and notification procedures regarding MD conducted studies

What do I need to do?

As a SP-INV, make yourself familiar with manufacturer responsibilities and how it relates to responsibilities regarding Medical Devices in the setting of a study.

Where can I get help?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

External Links

Swissmedic – see in particular

  • About us / publications / Swissmedic videos / about Medial Device (MD)
  • Medical Device / Market Surveillance
  • Medical Device / swissdamed – Swiss database in medical devices
  • Medical devices / regulation of medical devices / Information form the European environment

Swiss Law

TPA – see in particular articles

  • Art. 4 Medical Device (MD) definition
  • Art. 47109 Registration and device identification
  • Art. 47a110 Documentation requirements
  • Art. 47b111 Quality management
  • Art. 26 Principle of prescription, dispensing and application
  • Art. 48 Dispensing and use
  • Art. 62c151 Medical devices information system

MedDO – see in particular

  • Chapter 7 Device surveillance
Abbreviations
  • CTU – Clinical Trials Unit
  • DD – Device Deficiency
  • EU- European Union
  • MD –Medical Device
  • MedDO – Medical Devices Ordinance
  • SAD – Serious Device Event
  • SAE – Serious Adverse Event
  • SP-INV – Sponsor-Investigator
  • TPA - Therapeutic Products Act
Basic ↦ Drug or Device ↦ Medical Device ↦ Manufacture Responsibility
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Basic ↦ Drug or Device ↦ Medical Device ↦ Manufacture Responsibility

Please note: the Easy-GCS tool is currently under construction.